MTH1 Protein: A New Ally in the Fight Against Mesothelioma
|

MTH1 Protein: A New Ally in the Fight Against Mesothelioma

Scientists are now investigating a protein known as MTH1. They are delving into its role in boosting the body’s immune response against mesothelioma. This groundbreaking research holds the promise of more effective treatments for patients. Enhancing Mesothelioma Immunotherapy Mesothelioma is a challenging type of cancer that affects the lining of organs like the lungs. It is caused by exposure to asbestos, a toxic mineral used in construction and manufacturing. Scientists have been studying a protein called MTH1. They are looking at its potential role in helping the body’s immune system respond to this cancer. This research could lead to more effective treatments for mesothelioma patients. MTH1 is a protein that might have a significant impact on how the immune system…

Can TAMs Hold the Key to Stopping Cancer’s Advances?
|

Can TAMs Hold the Key to Stopping Cancer’s Advances?

TAMs are important cells found in cancer tumors. TAMs or tumor associated macrophages cause inflammation and stop the body from fighting the cancer. When a person has a lot of these cells, it means their cancer is harder to treat. A new study published in Frontiers in Immunology looked at whether using a drug to target TAMs can stop the spread of cancer. Targeting TAMs to Halt Cancer Spread Revealed in Recent Study The researchers in the study used a drug called alpha-ChemR23. This drug stops the TAMs from working, which might also stop the cancer tumors from spreading. They tested this drug in tumor samples taken from healthy people and from people with either breast cancer or mesothelioma in…